Research
U.S. demand for menopause hormone therapy has more than doubled recently
Science News · By Aimee Cunningham ·
The Brief
- A study of a U.S. pharmacy database found that use of menopause hormone therapy among women aged 40 to 74 rose from 2023 to 2026.
- The headline and report describe U.S. demand as having more than doubled recently.
- The source summary provides no further figures, causes or breakdowns.
Why it matters
Rising use of menopause hormone therapy suggests a major shift in how U.S. women in midlife are being treated, which matters for clinicians, researchers and public health planning.
Who’s affected
- women aged 40 to 74 in the United States
- clinicians who prescribe menopause hormone therapy
- #menopause
- #hormone therapy
- #women's health
- #pharmacy data
- #prescriptions
The use of menopause hormone therapy among women aged 40 to 74 rose from 2023 to 2026, suggests a study of a U.S. pharmacy database.